ATXN3 and Machado-Joseph disease: Our group recently developed an immunoassay that can detect the expanded ATXN3 protein (polyQ-ATXN3) in the cerebrospinal fluid (CSF), plasma, and urine of SCA3 patients (Prudencio et al., 2020; Koike et al., 2021).